Terms: = Lymphoma AND MED12, Q93074, TRAP230, TNRC11, OKS, KIAA0192, HOPA, FGS1, CAGH45, ARC240, 9968
16 results:
1. MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF.
Kondo N; Utsumi T; Shimizu Y; Takemoto A; Oh-Hara T; Uchibori K; Subat-Motoshi S; Ninomiya H; Takeuchi K; Nishio M; Miyazaki Y; Katayama R
JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37917191
[TBL] [Abstract] [Full Text] [Related]
2. Construction and validation of prognostic scoring models to risk stratify patients with acquired immune deficiency syndrome-related diffuse large B cell lymphoma.
Zhao H; Liu R; Tao Y; Bertero L; Feng L; Liu B; Chen Z; Guan J; Liao B; Li L; He H; You H
J Med Virol; 2023 May; 95(5):e28821. PubMed ID: 37227081
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases.
Bhatia P; Singh M; Singh A; Sharma P; Trehan A; Varma N
Int J Lab Hematol; 2021 Oct; 43(5):1016-1023. PubMed ID: 33538126
[TBL] [Abstract] [Full Text] [Related]
4. Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia-variant.
Locher M; Jukic E; Bohn JP; Untergasser G; Steurer M; Cramer CA; Schwendinger S; Vogi V; Verdorfer I; Witsch-Baumgartner M; Nachbaur D; Gunsilius E; Wolf D; Zschocke J; Steiner N
Genes Chromosomes Cancer; 2021 Apr; 60(4):287-292. PubMed ID: 33277788
[TBL] [Abstract] [Full Text] [Related]
5. Morphologic and genetic heterogeneity in breast fibroepithelial lesions-a comprehensive mapping study.
Tan BY; Md Nasir ND; Chang HY; Ng CCY; Guan P; Nagarajan S; Rajasegaran V; Lee JY; Lim JQ; Thike AA; Teh BT; Tan PH
Mod Pathol; 2020 Sep; 33(9):1732-1745. PubMed ID: 32322022
[TBL] [Abstract] [Full Text] [Related]
6. Genomic characterisation of breast fibroepithelial lesions in an international cohort.
Md Nasir ND; Ng CCY; Rajasegaran V; Wong SF; Liu W; Ng GXP; Lee JY; Guan P; Lim JQ; Thike AA; Koh VCY; Loke BN; Chang KTE; Gudi MA; Lian DWQ; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Tan P; Teh BT; Tan PH
J Pathol; 2019 Dec; 249(4):447-460. PubMed ID: 31411343
[TBL] [Abstract] [Full Text] [Related]
7. Modified enzyme multiplied immunoassay technique of methotrexate assay to improve sensitivity and reduce cost.
Shi X; Gao H; Li Z; Li J; Liu Y; Li L; Zhang Q
BMC Pharmacol Toxicol; 2019 Jan; 20(1):3. PubMed ID: 30626430
[TBL] [Abstract] [Full Text] [Related]
8. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell lymphoma, Leg Type.
Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
[TBL] [Abstract] [Full Text] [Related]
9. Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia.
De Bie J; Demeyer S; Alberti-Servera L; Geerdens E; Segers H; Broux M; De Keersmaecker K; Michaux L; Vandenberghe P; Voet T; Boeckx N; Uyttebroeck A; Cools J
Leukemia; 2018 Jun; 32(6):1358-1369. PubMed ID: 29740158
[TBL] [Abstract] [Full Text] [Related]
10. Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.
Vaisitti T; Braggio E; Allan JN; Arruga F; Serra S; Zamò A; Tam W; Chadburn A; Furman RR; Deaglio S
Cancer Res; 2018 Jul; 78(13):3413-3420. PubMed ID: 29735551
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistochemical profiling of receptor tyrosine kinases, med12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.
Yokouchi H; Nishihara H; Harada T; Ishida T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Higuchi M; Honjo O; Minami Y; Watanabe N; Goto A; Suzuki H; Dosaka-Akita H; Isobe H; Nishimura M; Munakata M
Oncotarget; 2017 Jun; 8(24):39711-39726. PubMed ID: 28055980
[TBL] [Abstract] [Full Text] [Related]
12. Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders.
Margolskee E; Jobanputra V; Jain P; Chen J; Ganapathi K; Nahum O; Levy B; Morscio J; Murty V; Tousseyn T; Alobeid B; Mansukhani M; Bhagat G
Oncotarget; 2016 Jun; 7(25):37636-37648. PubMed ID: 27203213
[TBL] [Abstract] [Full Text] [Related]
13. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
[TBL] [Abstract] [Full Text] [Related]
14. Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation.
Rubenstein M; Hollowell CM; Guinan P
In Vivo; 2015; 29(6):687-93. PubMed ID: 26546525
[TBL] [Abstract] [Full Text] [Related]
15. Epidemiology of oral Kaposi's sarcoma in Zimbabwe 1988-1997: a population-based study.
Marimo C
Cent Afr J Med; 2008; 54(1-4):15-9. PubMed ID: 21644423
[TBL] [Abstract] [Full Text] [Related]
16. Effects of nontoxic heat shock protein 90 inhibitor peptide derivatives on reversal of MDR of tumor cells.
Molnár J; Engi H; Mándi Y; Somlai C; Penke B; Szabó A; Orosz A
In Vivo; 2007; 21(2):429-33. PubMed ID: 17436599
[TBL] [Abstract] [Full Text] [Related]
